Rob Pieters

21PUBLICATIONS
162CO-AUTHORS
Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Cancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 11, 2026
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

|Jan 08, 2026
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha

|Oct 08, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

Louise Ahlgren, Mattias Pilheden, Helena Sturesson

|Feb 28, 2025
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL.

Judith M Boer, Marco J Koudijs, Lennart A Kester

|Sep 10, 2024
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

Janine Stutterheim, Rachella van der Waarden, Hester A de Groot-Kruseman

|Aug 28, 2024
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia.

Aimée S R Westerveld, Pien Roesthuis, Helena J H van der Pal

Pageof 4

Frequent Collaborators

5 joint publications

Andishe Attarbaschi

5 joint publications

Valérie de Haas

5 joint publications

Kjeld Schmiegelow

5 joint publications

Inge Van der Sluis